Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ORMPORMP
11 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in ORAMED PHARMACEUTICALS INC

WELLS FARGO & COMPANY/MN holds 157,586 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $535,791 as of 2026-Q1. The position was increased (+20.7% shares). ORMP represents 0.0% of WELLS FARGO & COMPANY/MN's portfolio.

Current Value

$535,791

Current Shares

157,586

Total Value Change

+$524,044

Total Shares Change

+153,085

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
157,586
+20.7%
$535,7910.0%$3.38
29
2025-Q4
Increased
130,586
+0.4%
$372,1690.0%$2.62
24
2025-Q3
Increased
130,086
+519.9%
$343,4260.0%$2.52
38
2025-Q2
Unchanged
20,986
0.0%
$47,2180.0%$2.00
0
2025-Q1
Decreased
20,986
-11.0%
$44,9090.0%$2.06
0
2024-Q4
Decreased
23,586
-6.0%
$57,0770.0%$2.17
0
2024-Q3
Decreased
25,086
-1.9%
$61,2090.0%$2.31
0
2024-Q2
Increased
25,586
+241.1%
$65,7550.0%$2.40
23
2024-Q1
Increased
7,501
+66.7%
$21,9020.0%$2.72
19
2023-Q4
Unchanged
4,501
0.0%
$10,3970.0%$2.15
0
2023-Q3
New
4,501
-
$11,7470.0%$2.43
27

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used